GlaxoSmithKline’s chief executive said a shareholder vote in favour of spinning off its consumer healthcare business vindicated the UK drugmaker’s decision to turn down a £50bn takeover offer from Unilever for its joint venture with Pfizer.
葛兰素史克(GlaxoSmithKline)首席执行官表示，股东投票赞成分拆消费者医疗保健业务，证明了这家英国制药商拒绝联合利华(Unilever)以500亿英镑收购其与辉瑞(Pfizer)合资企业的决定是正确的。
您已阅读8%（347字），剩余92%（3837字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。